Chris Miller
TitleCited byYear
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network
Nature 455 (7216), 1061, 2008
46982008
Mutational landscape and significance across 12 major cancer types
C Kandoth, MD McLellan, F Vandin, K Ye, B Niu, C Lu, M Xie, Q Zhang, ...
Nature 502 (7471), 333, 2013
24142013
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KRM Shaw, BA Ozenberger, ...
Nature genetics 45 (10), 1113, 2013
23792013
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
DC Koboldt, Q Zhang, DE Larson, D Shen, MD McLellan, L Lin, CA Miller, ...
Genome Research 22 (3), 568-576, 2012
23052012
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
TCGAR Network
New England Journal of Medicine 368 (22), 2059-2074, 2013
2084*2013
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543, 2014
18152014
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
L Ding, TJ Ley, DE Larson, CA Miller, DC Koboldt, JS Welch, JK Ritchey, ...
Nature, 2012
16052012
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ...
Cell 150 (2), 264-278, 2012
10712012
Age-related mutations associated with clonal hematopoietic expansion and malignancies
M Xie, C Lu, J Wang, MD McLellan, KJ Johnson, MC Wendl, ...
Nature medicine 20 (12), 1472, 2014
8422014
Whole-genome analysis informs breast cancer response to aromatase inhibition
MJ Ellis, L Ding, D Shen, J Luo, VJ Suman, JW Wallis, BA Van Tine, ...
Nature 486 (7403), 353, 2012
8392012
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts
S Li, D Shen, J Shao, R Crowder, W Liu, A Prat, X He, S Liu, J Hoog, C Lu, ...
Cell reports 4 (6), 1116-1130, 2013
3892013
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
TN Wong, G Ramsingh, AL Young, CA Miller, W Touma, JS Welch, ...
Nature 518 (7540), 552, 2015
3602015
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ...
New England Journal of Medicine 375 (21), 2023-2036, 2016
2922016
DGIdb: mining the druggable genome
M Griffith, OL Griffith, AC Coffman, JV Weible, JF McMichael, NC Spies, ...
Nature methods 10 (12), 1209, 2013
2872013
Functional heterogeneity of genetically defined subclones in acute myeloid leukemia
JM Klco, DH Spencer, CA Miller, M Griffith, TL Lamprecht, M O’Laughlin, ...
Cancer cell 25 (3), 379-392, 2014
2562014
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution
CA Miller, BS White, ND Dees, M Griffith, JS Welch, OL Griffith, R Vij, ...
PLoS computational biology 10 (8), e1003665, 2014
2392014
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
MJ Walter, D Shen, J Shao, L Ding, BS White, C Kandoth, CA Miller, B Niu, ...
Leukemia 27 (6), 1275, 2013
2242013
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers
DA Russler-Germain, DH Spencer, MA Young, TL Lamprecht, CA Miller, ...
Cancer cell 25 (4), 442-454, 2014
2202014
Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia
JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ...
Jama 314 (8), 811-822, 2015
1972015
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells
MA Young, DE Larson, CW Sun, DR George, L Ding, CA Miller, L Lin, ...
Cell stem cell 10 (5), 570-582, 2012
1932012
The system can't perform the operation now. Try again later.
Articles 1–20